Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HNY8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 176 | 178 | PF00675 | 0.489 |
CLV_NRD_NRD_1 | 210 | 212 | PF00675 | 0.467 |
CLV_NRD_NRD_1 | 220 | 222 | PF00675 | 0.469 |
CLV_PCSK_FUR_1 | 208 | 212 | PF00082 | 0.606 |
CLV_PCSK_KEX2_1 | 176 | 178 | PF00082 | 0.486 |
CLV_PCSK_KEX2_1 | 208 | 210 | PF00082 | 0.472 |
CLV_PCSK_KEX2_1 | 220 | 222 | PF00082 | 0.455 |
CLV_PCSK_PC1ET2_1 | 220 | 222 | PF00082 | 0.351 |
CLV_PCSK_SKI1_1 | 217 | 221 | PF00082 | 0.546 |
CLV_PCSK_SKI1_1 | 230 | 234 | PF00082 | 0.363 |
CLV_PCSK_SKI1_1 | 241 | 245 | PF00082 | 0.287 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.407 |
DOC_CKS1_1 | 155 | 160 | PF01111 | 0.623 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 14 | 21 | PF00134 | 0.447 |
DOC_MAPK_MEF2A_6 | 14 | 21 | PF00069 | 0.337 |
DOC_PP2B_LxvP_1 | 106 | 109 | PF13499 | 0.484 |
DOC_USP7_MATH_1 | 112 | 116 | PF00917 | 0.600 |
DOC_USP7_MATH_1 | 134 | 138 | PF00917 | 0.628 |
DOC_USP7_MATH_1 | 147 | 151 | PF00917 | 0.616 |
DOC_WW_Pin1_4 | 154 | 159 | PF00397 | 0.651 |
DOC_WW_Pin1_4 | 163 | 168 | PF00397 | 0.538 |
DOC_WW_Pin1_4 | 251 | 256 | PF00397 | 0.696 |
LIG_14-3-3_CanoR_1 | 116 | 121 | PF00244 | 0.660 |
LIG_14-3-3_CanoR_1 | 185 | 190 | PF00244 | 0.600 |
LIG_Actin_WH2_2 | 57 | 75 | PF00022 | 0.341 |
LIG_APCC_ABBA_1 | 64 | 69 | PF00400 | 0.355 |
LIG_BIR_III_2 | 22 | 26 | PF00653 | 0.227 |
LIG_BRCT_BRCA1_1 | 123 | 127 | PF00533 | 0.493 |
LIG_FHA_1 | 121 | 127 | PF00498 | 0.653 |
LIG_FHA_1 | 213 | 219 | PF00498 | 0.586 |
LIG_LIR_Gen_1 | 124 | 134 | PF02991 | 0.501 |
LIG_LIR_Gen_1 | 56 | 67 | PF02991 | 0.457 |
LIG_LIR_Gen_1 | 85 | 94 | PF02991 | 0.333 |
LIG_LIR_Nem_3 | 124 | 130 | PF02991 | 0.496 |
LIG_LIR_Nem_3 | 237 | 243 | PF02991 | 0.471 |
LIG_LIR_Nem_3 | 85 | 89 | PF02991 | 0.333 |
LIG_SH2_CRK | 86 | 90 | PF00017 | 0.335 |
LIG_SH2_SRC | 67 | 70 | PF00017 | 0.335 |
LIG_SH2_STAP1 | 67 | 71 | PF00017 | 0.335 |
LIG_SH2_STAP1 | 86 | 90 | PF00017 | 0.150 |
LIG_SH2_STAT3 | 90 | 93 | PF00017 | 0.335 |
LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.355 |
LIG_SH3_2 | 109 | 114 | PF14604 | 0.600 |
LIG_SH3_3 | 105 | 111 | PF00018 | 0.306 |
LIG_SH3_3 | 152 | 158 | PF00018 | 0.634 |
LIG_SH3_3 | 52 | 58 | PF00018 | 0.432 |
LIG_SH3_3 | 88 | 94 | PF00018 | 0.341 |
LIG_WW_3 | 107 | 111 | PF00397 | 0.527 |
MOD_CDC14_SPxK_1 | 166 | 169 | PF00782 | 0.562 |
MOD_CDK_SPxK_1 | 163 | 169 | PF00069 | 0.584 |
MOD_CK1_1 | 115 | 121 | PF00069 | 0.715 |
MOD_CK1_1 | 135 | 141 | PF00069 | 0.654 |
MOD_CK1_1 | 163 | 169 | PF00069 | 0.542 |
MOD_CK1_1 | 228 | 234 | PF00069 | 0.395 |
MOD_CK2_1 | 116 | 122 | PF00069 | 0.494 |
MOD_CK2_1 | 188 | 194 | PF00069 | 0.496 |
MOD_CK2_1 | 51 | 57 | PF00069 | 0.266 |
MOD_GlcNHglycan | 122 | 126 | PF01048 | 0.645 |
MOD_GlcNHglycan | 134 | 137 | PF01048 | 0.543 |
MOD_GlcNHglycan | 142 | 145 | PF01048 | 0.756 |
MOD_GlcNHglycan | 149 | 152 | PF01048 | 0.720 |
MOD_GlcNHglycan | 162 | 165 | PF01048 | 0.663 |
MOD_GlcNHglycan | 230 | 233 | PF01048 | 0.525 |
MOD_GlcNHglycan | 46 | 49 | PF01048 | 0.408 |
MOD_GSK3_1 | 112 | 119 | PF00069 | 0.697 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.644 |
MOD_GSK3_1 | 132 | 139 | PF00069 | 0.549 |
MOD_GSK3_1 | 184 | 191 | PF00069 | 0.517 |
MOD_GSK3_1 | 49 | 56 | PF00069 | 0.356 |
MOD_GSK3_1 | 72 | 79 | PF00069 | 0.419 |
MOD_N-GLC_1 | 50 | 55 | PF02516 | 0.341 |
MOD_NEK2_1 | 120 | 125 | PF00069 | 0.704 |
MOD_NEK2_1 | 49 | 54 | PF00069 | 0.285 |
MOD_NEK2_1 | 72 | 77 | PF00069 | 0.466 |
MOD_PIKK_1 | 225 | 231 | PF00454 | 0.602 |
MOD_PIKK_1 | 93 | 99 | PF00454 | 0.463 |
MOD_PK_1 | 76 | 82 | PF00069 | 0.349 |
MOD_PKA_2 | 115 | 121 | PF00069 | 0.746 |
MOD_PKA_2 | 184 | 190 | PF00069 | 0.575 |
MOD_PKA_2 | 72 | 78 | PF00069 | 0.480 |
MOD_PKB_1 | 114 | 122 | PF00069 | 0.735 |
MOD_Plk_1 | 121 | 127 | PF00069 | 0.618 |
MOD_Plk_1 | 17 | 23 | PF00069 | 0.278 |
MOD_Plk_1 | 50 | 56 | PF00069 | 0.258 |
MOD_Plk_4 | 116 | 122 | PF00069 | 0.534 |
MOD_Plk_4 | 60 | 66 | PF00069 | 0.449 |
MOD_ProDKin_1 | 154 | 160 | PF00069 | 0.648 |
MOD_ProDKin_1 | 163 | 169 | PF00069 | 0.534 |
MOD_ProDKin_1 | 251 | 257 | PF00069 | 0.738 |
TRG_DiLeu_BaEn_1 | 214 | 219 | PF01217 | 0.577 |
TRG_DiLeu_BaEn_1 | 246 | 251 | PF01217 | 0.578 |
TRG_DiLeu_BaEn_2 | 238 | 244 | PF01217 | 0.480 |
TRG_DiLeu_LyEn_5 | 214 | 219 | PF01217 | 0.577 |
TRG_ENDOCYTIC_2 | 67 | 70 | PF00928 | 0.386 |
TRG_ENDOCYTIC_2 | 86 | 89 | PF00928 | 0.150 |
TRG_ER_diArg_1 | 113 | 116 | PF00400 | 0.435 |
TRG_ER_diArg_1 | 208 | 211 | PF00400 | 0.428 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2R9 | Leptomonas seymouri | 54% | 93% |
A0A0S4J2G2 | Bodo saltans | 43% | 100% |
A0A1X0P9F2 | Trypanosomatidae | 44% | 100% |
A0A3Q8IH20 | Leishmania donovani | 76% | 100% |
A0A422N0I0 | Trypanosoma rangeli | 41% | 100% |
A4ICK5 | Leishmania infantum | 76% | 100% |
E9ASQ0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 75% | 100% |
Q4Q1U5 | Leishmania major | 74% | 100% |
V5BQB2 | Trypanosoma cruzi | 43% | 100% |